Kurvelo Kit
Product Images NDC 68180-844

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Kurvelo (NDC 68180-844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 01

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 02

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 03

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 03
This is a chart detailing the number of women with a blood clot out of 10,000 women years (WY), broken down into different categories. The categories include Non-Pregnant Ranges for both COC-users and non-users, Pregnancy Ranges based on actual pregnancy duration or a model assumption of nine months, and Postpartum Ranges for up to 12 weeks after delivery. The chart shows that the rate of blood clots varies depending on the category, with the highest rates being for COC-users and pregnant women (whether actual duration or model assumption).*
FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 04

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 05

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 05
This text presents information on the different pregnancy rates according to contraceptive methods, with the lowest rate being fewer than 1 pregnancy per 100 women in one year and the highest being 85 or more pregnancies per 100 women in one year. It also mentions various contraceptive methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The final option presented is no birth control.*
FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 06

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 07

FDA Label Image

12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 08

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.